Viridian is dedicated to improving patients’ lives through the discovery and development of RNA-based therapeutics, with a specific focus on microRNAs.

Biotechnology

Viridian Therapeutics

Shan Wu

Melissa Manno

Jason A. Leverone

Angela She

Mark Howansky

Steve Graunke

Partha Ghosh

Rochelle Summerfelt

Shula Pollard

Angela Doyle

Chelsea Gordon

Thomas Beetham

Kellie Dinapoli

Lucy Weng

Valerie Smith

Cindy Durkin

The Scientific Team at Viridian Therapeutics drives the discovery and development of RNA-based therapeutics, concentrating on microRNA innovations. They conduct cutting-edge research, develop and refine processes, ensure regulatory compliance, and effectively communicate scientific advancements to support drug development and enhance patient outcomes.

Scientific Team

Advisory Team

Quality Control and Operations

Scientific Team

About

Team members

Other teams at Viridian Therapeutics

Advisory Team

Quality Control and Operations